Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...

The company has been granted a 45-day period to submit a plan to regain compliance with Nasdaq listing requirements, indicating that there is a pathway for continued listing on the exchange.

The company expects to regain compliance with Nasdaq Listing Rule 5250(c)(1), which ... therapies and the potential for unmet regulatory requirements. The press release contains a range of forward ...

Mustang Bio announces a 1-for-50 reverse stock split to comply with Nasdaq listing requirements, effective January 16, 2025. Mustang Bio, Inc. has announced a 1-for-50 reverse stock split of its ...

Horizon Aircraft Shares to Remain Listed on NasdaqTORONTO, Ontario, Jan. 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), a ...

New Horizon Aircraft (HOVR) announced that it has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market ...

The appeal process demonstrates the Company's proactive approach to addressing compliance issues with Nasdaq listing requirements. The company received a delisting determination from Nasdaq ...

Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to the Nasdaq minimum ...

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements ...

or any of Nasdaq's alternative continued listing requirements under Nasdaq Listing Rule 5550 for companies traded on the Nasdaq Capital Market and meet the required milestones outlined in the ...

Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company, announced on Monday, that it has regained compliance with Nasdaq's ...

Nature's Miracle is working with legal counsel to ensure compliance with all regulatory requirements and to ... in its commitment to restoring its Nasdaq listing and enhancing shareholder value.